Silverfin false false 31/01/2026 01/02/2025 31/01/2026 A Caunce 31/01/2026 Gorgemead Limited 31/01/2026 U Patel 31/01/2026 22/01/2000 V Patel 31/01/2026 22/01/2000 26 October 2026 The principal activity of the year continued to be that of retail pharmaceutical chemists. 03903928 2026-01-31 03903928 bus:Director1 2026-01-31 03903928 bus:Director2 2026-01-31 03903928 bus:Director3 2026-01-31 03903928 bus:Director4 2026-01-31 03903928 2025-01-31 03903928 core:CurrentFinancialInstruments 2026-01-31 03903928 core:CurrentFinancialInstruments 2025-01-31 03903928 core:ShareCapital 2026-01-31 03903928 core:ShareCapital 2025-01-31 03903928 core:RetainedEarningsAccumulatedLosses 2026-01-31 03903928 core:RetainedEarningsAccumulatedLosses 2025-01-31 03903928 core:Goodwill 2025-01-31 03903928 core:Goodwill 2026-01-31 03903928 core:LandBuildings 2025-01-31 03903928 core:FurnitureFittings 2025-01-31 03903928 core:LandBuildings 2026-01-31 03903928 core:FurnitureFittings 2026-01-31 03903928 2025-02-01 2026-01-31 03903928 bus:FilletedAccounts 2025-02-01 2026-01-31 03903928 bus:SmallEntities 2025-02-01 2026-01-31 03903928 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 03903928 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 03903928 bus:Director1 2025-02-01 2026-01-31 03903928 bus:Director2 2025-02-01 2026-01-31 03903928 bus:Director3 2025-02-01 2026-01-31 03903928 bus:Director4 2025-02-01 2026-01-31 03903928 core:Goodwill core:TopRangeValue 2025-02-01 2026-01-31 03903928 core:LandBuildings core:TopRangeValue 2025-02-01 2026-01-31 03903928 core:FurnitureFittings core:TopRangeValue 2025-02-01 2026-01-31 03903928 2024-02-01 2025-01-31 03903928 core:LandBuildings 2025-02-01 2026-01-31 03903928 core:FurnitureFittings 2025-02-01 2026-01-31 iso4217:GBP xbrli:pure

Company No: 03903928 (England and Wales)

WHITTLE PHARMACIES LIMITED

Unaudited Financial Statements
For the financial year ended 31 January 2026
Pages for filing with the registrar

WHITTLE PHARMACIES LIMITED

Unaudited Financial Statements

For the financial year ended 31 January 2026

Contents

WHITTLE PHARMACIES LIMITED

BALANCE SHEET

As at 31 January 2026
WHITTLE PHARMACIES LIMITED

BALANCE SHEET (continued)

As at 31 January 2026
Note 2026 2025
£ £
Fixed assets
Tangible assets 4 189,060 227,930
189,060 227,930
Current assets
Stocks 220,004 209,752
Debtors 5 647,549 1,435,603
Cash at bank and in hand 6 419,620 531,414
1,287,173 2,176,769
Creditors: amounts falling due within one year 7 ( 977,032) ( 1,046,809)
Net current assets 310,141 1,129,960
Total assets less current liabilities 499,201 1,357,890
Net assets 499,201 1,357,890
Capital and reserves
Called-up share capital 440 440
Profit and loss account 498,761 1,357,450
Total shareholder's funds 499,201 1,357,890

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Whittle Pharmacies Limited (registered number: 03903928) were approved and authorised for issue by the Board of Directors on 26 October 2026. They were signed on its behalf by:

A Caunce
Director
WHITTLE PHARMACIES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
WHITTLE PHARMACIES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Whittle Pharmacies Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lynstock House Lynstock Way, Lostock, Bolton, BL6 4SA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 20 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 25 years straight line
Fixtures and fittings 15 years straight line
Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 55 60

3. Intangible assets

Goodwill Total
£ £
Cost
At 01 February 2025 3,397,627 3,397,627
At 31 January 2026 3,397,627 3,397,627
Accumulated amortisation
At 01 February 2025 3,397,627 3,397,627
At 31 January 2026 3,397,627 3,397,627
Net book value
At 31 January 2026 0 0
At 31 January 2025 0 0

4. Tangible assets

Land and buildings Fixtures and fittings Total
£ £ £
Cost
At 01 February 2025 761,760 170,544 932,304
Disposals ( 56,876) 0 ( 56,876)
At 31 January 2026 704,884 170,544 875,428
Accumulated depreciation
At 01 February 2025 537,432 166,942 704,374
Charge for the financial year 29,712 1,575 31,287
Disposals ( 49,293) 0 ( 49,293)
At 31 January 2026 517,851 168,517 686,368
Net book value
At 31 January 2026 187,033 2,027 189,060
At 31 January 2025 224,328 3,602 227,930

5. Debtors

2026 2025
£ £
Trade debtors 548,461 1,158,890
Corporation tax 0 17,813
Other debtors 99,088 258,900
647,549 1,435,603

6. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 419,620 531,414

7. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 896,155 979,871
Other taxation and social security 26,049 28,205
Other creditors 54,828 38,733
977,032 1,046,809